ºÐÀÚ»ý¹°Çпë È¿¼Ò, ŰƮ, ½Ã¾à ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)
Molecular Biology Enzymes, Reagents And Kits Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Enzymes), By Application (Cloning, Sequencing), By End Use (Academic & Research), By Region, And Segment Forecasts, 2025 - 2033
»óǰÄÚµå
:
1790320
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2025³â 07¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 275 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå °³¿ä
¼¼°èÀÇ DNA ¸ÞÆ¿È ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 14¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2025-2033³â¿¡ CAGR 9.99%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 341¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀº ƯÈ÷ Á¦¾à ¹× »ý¸í°øÇÐ ¿¬±¸ µî ±¤¹üÀ§ÇÑ ºÐÀÚ»ý¹°ÇÐÀû ¿ëµµ¿¡¼ À̵é Á¦Ç°ÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.
Á¤¹ÐÁø´Ü, ÀǾàǰ °³¹ß, À¯Àüü ºÐ¼®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ½Å·ÚÇÒ ¼ö ÀÖ°í È¿À²ÀûÀÎ ºÐÀÚ Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ºÐÀÚ °Ë»ç Ç÷§ÆûÀÇ °¡¿ë¼º È®´ë´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ÀÚµ¿È ¹× °í󸮷® ¿öÅ©Ç÷ο쿡 ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼ Çмú ¹× »ó¾÷¿ë ½ÇÇè½Ç ¸ðµÎ¿¡¼ ÷´Ü ŰƮ, ½Ã¾à ¹× È¿¼ÒÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
½ÃÄö½Ì ±â¼úÀÇ Àû¿ë È®´ë·Î À¯ÀüüÇаú ºÐÀÚ»ý¹°ÇÐÀº Å©°Ô º¯¸ðÇÏ¿© ³ôÀº Á¤È®µµ¿Í È¿À²ÀûÀÎ ¿¬±¸°¡ °¡´ÉÇØÁ³½À´Ï´Ù. Â÷¼¼´ë ¿°±â¼¿ ºÐ¼®(NGS)ÀÇ µîÀåÀ¸·Î DNA ¿°±â¼¿ ºÐ¼®Àº ´õ¿í Ä£¼÷ÇÏ°í ºñ¿ë È¿À²ÀûÀÌ µÇ¾úÀ¸¸ç, 3¼¼´ë Ç÷§ÆûÀº À¯Àüü Á¶¸³, ÇÏÇÁ·ÎÀ¯Çü À§»ó ºÐ¼®, ±¸Á¶Àû º¯ÀÌ ºÐ¼®ÀÇ °úÁ¦¸¦ ÇØ°áÇϰí ÀÖ½À´Ï´Ù. ½ÃÄö½Ì ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÷´Ü ¿¬±¸¸¦ Áö¿øÇϴ Ư¼ö ½Ã¾à ¹× ŰƮÀÇ Áö¼ÓÀûÀÎ °³¹ß·Î À̾îÁ³½À´Ï´Ù. 2024³â 11¿ù, ͏®Æ÷´Ï¾ÆÁÖ °øÁߺ¸°Ç±¹(CDPH)Àº ½ÇÇè½Ç °Ë»ç¸¦ ÅëÇØ ¹Ì±¹ ÃÖÃÊÀÇ ¼öµÎ »ç·Ê¸¦ È®ÀÎÇß½À´Ï´Ù. ÀÌ »ç·Ê´Â PCRÀ» ÅëÇØ È®ÀεǾú°í, ¿°±â¼¿ ºÐ¼®À¸·Î È®ÁøµÇ¾ú½À´Ï´Ù. ÀÌ »ç·Ê´Â ½Å¼ÓÇϰí Á¤È®ÇÑ ºÐÀÚÁø´ÜÀÇ Á߿伺À» °Á¶Çϰí, ÷´Ü PCR ¹× ¿°±â¼¿ ºÐ¼® ÅøÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ¿© ºÐÀÚ»ý¹°ÇÐÀû È¿¼Ò, ½Ã¾à ¹× ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ ¹ßÀü¿¡µµ ºÒ±¸ÇÏ°í µ¥ÀÌÅÍ º¸¾È°ú ½ºÅ丮Áö ÀÎÇÁ¶ó¿¡ ´ëÇÑ ¿ì·Á´Â ¿©ÀüÈ÷ °úÁ¦·Î ³²¾ÆÀÖ½À´Ï´Ù. ½ÃÄö½ÌÀ» ÅëÇØ »ý¼ºµÈ ¹æ´ëÇÑ µ¥ÀÌÅͼ¼Æ®¿¡´Â ¹Î°¨ÇÑ À¯ÀüÁ¤º¸°¡ Æ÷ÇԵǾî ÀÖÀ¸¹Ç·Î À±¸®ÀûÀÎ Ãë±Þ°ú ¾ÈÀüÇÑ º¸°üÀÌ ÇÊ¿äÇϸç, ÀÌ´Â ´ëºÎºÐ Ŭ¶ó¿ìµå ±â¹Ý ±â¼úÀ» ÅëÇØ ÀÌ·ç¾îÁý´Ï´Ù. ½ÅÈï ±¹°¡¿¡¼´Â °í±Þ µ¥ÀÌÅÍ ½ºÅ丮Áö ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇѵǾî ÀÖÀ¸¸ç, ½ÃÄö½Ì ÅøÀÇ ±¤¹üÀ§ÇÑ µµÀÔÀ» ¹æÇØÇÏ°í ½ÃÀå¿¡ °£Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª Á¤ºÎ ÁÖµµÀÇ ¹ÙÀÌ¿À¹ðÅ© ¼³¸³ ³ë·Â°ú ±¹°¡ À¯Àüü ÇÁ·ÎÁ§Æ®´Â ÀÌ·¯ÇÑ ¿ì·Á¸¦ ÀϺΠ¿ÏÈÇϰí Àå±âÀûÀÎ ¹ßÀüÀ» Áö¿øÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : °³¿ä
½ÃÀå ½º³À¼ô
Á¦Ç°°ú ¿ëµµ ½º³À¼ô
ÃÖÁ¾ ¿ëµµ ½º³À¼ô
°æÀï ±¸µµ ÇöȲ
Á¦3Àå ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
½ÃÀå ¼¼ºÐÈ¿Í ¹üÀ§
½ÃÀå °èÅë Àü¸Á
¸ð½ÃÀå Àü¸Á
°ü·Ã/º¸Á¶ ½ÃÀå Àü¸Á
½ÃÀå ¿ªÇÐ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
Porter's Five Forces ºÐ¼®
PESTLE ºÐ¼®
Á¦4Àå ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : Á¦Ç°º°, ÃßÁ¤¡¤µ¿Ç⠺м®
Á¦Ç° ½ÃÀå Á¡À¯À², 2024³â°ú 2033³â
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : Á¦Ç° Àü¸Áº°
2021-2033³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
Á¦5Àå ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®
¿ëµµ ½ÃÀå Á¡À¯À², 2024³â°ú 2033³â
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : ¿ëµµº° Àü¸Á
2021-2033³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
Ŭ·Ð
½ÃÄö½º
PCR
¿¡ÇÇÁ¦³×ƽ½º
À¯ÀüÀÚÇü ÆÇÁ¤
RCA/MDA
RNA Therapeutics
Àü»çüÇÐ
´Ü¹éÁúüÇÐ
¾×ü»ý°Ë
±âŸ
Á¦6Àå ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®
ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â°ú 2033³â
ºÎ¹® ´ë½Ãº¸µå
¼¼°èÀÇ ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : ÃÖÁ¾ ¿ëµµº° Àü¸Á
2021-2033³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
Á¦¾à ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö
Çмú¿¬±¸
º´¿ø & Áø´Ü
±âŸ
Á¦7Àå ºÐÀÚ»ý¹°Çпë È¿¼Ò¡¤Å°Æ®¡¤½Ã¾à ½ÃÀå : Áö¿ªº° ºñÁî´Ï½º ºÐ¼®
Áö¿ª ½ÃÀå ½º³À¼ô
ºÏ¹Ì
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
KSA
¿µ¹® ¸ñÂ÷
Molecular Biology Enzymes, Reagents And Kits Market Summary
The global DNA methylation market size was valued at USD 1.47 billion in 2023 and is projected to reach USD 34.11 billion by 2030, growing at a CAGR of 9.99% from 2025 to 2033. Market expansion is driven by the growing adoption of these products across a wide range of molecular biology applications, particularly in pharmaceutical and biotechnology research.
Increasing focus on precision diagnostics, drug development, and genomic analysis continues to support the demand for reliable and efficient molecular tools. Rising investments in life sciences research and the expanding availability of molecular testing platforms are further supporting market growth. In particular, the growing emphasis on automation and high-throughput workflows is encouraging the adoption of advanced kits, reagents, and enzymes across both academic and commercial laboratories.
The expanding application of sequencing technologies has significantly transformed genomics and molecular biology, enabling highly accurate and efficient research. The emergence of next-generation sequencing (NGS) has made DNA sequencing more accessible and cost-effective, while third-generation platforms are addressing challenges in genome assembly, haplotype phasing, and structural variation analysis. The rising demand for sequencing solutions has led to the continuous development of specialized reagents and kits that support advanced research. In November 2024, the California Department of Public Health (CDPH) confirmed the first case of clade I mpox in the U.S. through laboratory testing. The case, identified via PCR and confirmed through further sequencing, highlights the importance of rapid and precise molecular diagnostics, driving the adoption of advanced PCR and sequencing tools and supporting the growth of the molecular biology enzymes, reagents, and kits market.
Despite these advances, data security and storage infrastructure concerns pose a challenge. The massive datasets generated through sequencing contain sensitive genetic information, requiring ethical handling and secure storage, often through cloud-based technologies. In emerging economies, limited access to high-end data storage solutions may hinder the broader adoption of sequencing tools, indirectly affecting the market. However, government-led efforts to establish biobanks and national genome initiatives are expected to mitigate some of these concerns and support long-term market development.
Global Molecular Biology Enzymes, Reagents And Kits Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global molecular biology enzymes, reagents, and kits market report based on product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2021 - 2033)
Kits & Reagents
PCR Kits
qPCR Kits
RT-PCR Kits
Library Preparation Kits
Cloning Kits
Purification Kits
Gene Editing Kits
Other Kits
Enzymes
Polymerases
High Fidelity DNA Polymerases
Pfu DNA Polymerases
Phusion DNA Polymerases
Hot Start DNA Polymerases
Taq DNA Polymerases High Fidelity
Others
Thermostable DNA Polymerases
Standard Taq DNA Polymerases
Tth DNA Polymerases
Others
Strand-displacing DNA Polymerases
Bst DNA Polymerases
Phi29 DNA Polymerases
Others
T7 RNA Polymerase
SP6 RNA Polymerase
T3 RNA Polymerase
Other RNA Polymerase
Reverse Transcriptase (RTs)
M-MLV RT
AMV RT
Thermostable RT
Template Switch
TGIRT
Induro
MarathonRT
Ligases
T4 DNA Ligases
E coli DNA Ligase
Taq DNA Ligase
Others
Nucleases
DNase I
RNase A, RNase H
Nickases
Restriction Nucleases
TdTs
Endonucleases
Kinases
Phosphatases
CRISPR-associated Enzymes
Cas9
Cas12a (Cpf1)
Cas13
Specialty Enzymes
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Cloning
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Sequencing
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
PCR
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Epigenetics
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Genotyping
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
RCA/MDA
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
RNA Therapeutics
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Transcriptomics
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Proteomics
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Liquid Biopsy
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Other Applications
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharma & Biotech
Research
Therapeutics/Production
Academic & Research
Hospital & Diagnostics
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Molecular Biology Enzymes, Reagents and Kits Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. Application Segment
1.1.1.3. End use segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR's Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Molecular Biology Enzymes, Reagents and Kits Market: Executive Summary
2.1. Market Snapshot
2.2. Product and Application Snapshot
2.3. End use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Molecular Biology Enzymes, Reagents and Kits Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraint Analysis
3.4. Porter's Five Forces Analysis
3.5. PESTLE Analysis
Chapter 4. Molecular Biology Enzymes, Reagents and Kits Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Molecular Biology Enzymes, Reagents And Kits Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. Kits & Reagents
4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2. PCR Kits
4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.3. qPCR Kits
4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.4. RT-PCR Kits
4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.5. Library Preparation Kits
4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.6. Cloning Kits
4.4.1.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.7. Purification Kits
4.4.1.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.8. Gene Editing Kits
4.4.1.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.9. Other Kits
4.4.1.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Enzymes
4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2. Polymerases
4.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2. DNA Polymerases
4.4.2.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.2. High Fidelity DNA Polymerases
4.4.2.2.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.2.2. Pfu DNA Polymerases
4.4.2.2.2.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.2.3. Phusion DNA Polymerases
4.4.2.2.2.2.4. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.2.5. Hot Start DNA Polymerases
4.4.2.2.2.2.6. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.2.7. Taq DNA Polymerases High Fidelity
4.4.2.2.2.3. Thermostable DNA Polymerases
4.4.2.2.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.3.2. Standard Taq DNA Polymerases
4.4.2.2.2.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.3.3. Tth DNA Polymerases
4.4.2.2.2.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.4. Strand-displacing DNA Polymerases
4.4.2.2.2.5. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.2.6. Bst DNA Polymerases
4.4.2.2.2.6.1. Market estimates and forecasts 2021 to 2033 (USD Million
4.4.2.2.2.7. Phi29 DNA Polymerases
4.4.2.2.2.7.1. Market estimates and forecasts 2021 to 2033 (USD Million
4.4.2.2.2.8. Others
4.4.2.2.2.8.1. Market estimates and forecasts 2021 to 2033 (USD Million
4.4.2.2.3. RNA Polymerases
4.4.2.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.3.2. T7 RNA Polymerase
4.4.2.2.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.3.3. SP6 RNA Polymerase
4.4.2.2.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.3.4. T3 RNA Polymerase
4.4.2.2.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2.3.5. Other RNA Polymerase
4.4.2.2.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3. Reverse Transcriptase (RTs)
4.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3.2. M-MLV RT
4.4.2.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3.3. AMV RT
4.4.2.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3.4. Thermostable RT
4.4.2.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3.5. Template Switch
4.4.2.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3.6. TGIRT
4.4.2.3.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3.7. Induro
4.4.2.3.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3.8. MarathonRT
4.4.2.3.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.4. Ligases
4.4.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.4.2. DNA Ligases
4.4.2.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.4.2.2. T4 DNA Ligases
4.4.2.4.2.3. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.4.2.3.1.
4.4.2.4.2.4. E coli DNA Ligase
4.4.2.4.2.5. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.4.2.6. Taq DNA Ligase
4.4.2.4.2.7. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.4.2.8. Others
4.4.2.4.2.9. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.4.3. RNA Ligases
4.4.2.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.5. Nucleases
4.4.2.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.5.2. DNase I
4.4.2.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.5.3. RNase A, RNase H
4.4.2.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.5.4. Nickases
4.4.2.5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.5.5. Restriction Nucleases
4.4.2.5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.5.6. TdTs
4.4.2.5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.6. Endonucleases
4.4.2.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.6.2. EndoQ
4.4.2.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.6.3. AP Nuclease
4.4.2.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.7. Kinases
4.4.2.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.8. Phosphatases
4.4.2.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.9. CRISPR-associated Enzymes
4.4.2.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.9.2. Cas9
4.4.2.9.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.9.3. Cas12a (Cpf1)
4.4.2.9.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.9.4. Cas13
4.4.2.9.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.10. Specialty Enzymes
4.4.2.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.11. Others
4.4.2.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Molecular Biology Enzymes, Reagents and Kits Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Molecular Biology Enzymes, Reagents And Kits Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.4.1. Cloning
5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.2. Pharma & Biotech
5.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.2.2. Research
5.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.2.3. Therapeutics/Production
5.4.1.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.3. Academic & Research
5.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.4. Hospital & Diagnostics
5.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.5. Others
5.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Sequencing
5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2. Pharma & Biotech
5.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2.2. Research
5.4.2.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2.3. Therapeutics/Production
5.4.2.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.3. Academic & Research
5.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.4. Hospital & Diagnostics
5.4.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.5. Others
5.4.2.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3. PCR
5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3.2. Pharma & Biotech
5.4.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3.2.2. Research
5.4.3.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3.2.3. Therapeutics/Production
5.4.3.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3.3. Academic & Research
5.4.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3.4. Hospital & Diagnostics
5.4.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3.5. Others
5.4.3.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4. Epigenetics
5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4.2. Pharma & Biotech
5.4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4.2.2. Research
5.4.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4.2.3. Therapeutics/Production
5.4.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4.3. Academic & Research
5.4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4.4. Hospital & Diagnostics
5.4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.4.5. Others
5.4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5. Genotyping
5.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5.2. Pharma & Biotech
5.4.5.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5.2.2. Research
5.4.5.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5.2.3. Therapeutics/Production
5.4.5.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5.3. Academic & Research
5.4.5.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5.4. Hospital & Diagnostics
5.4.5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.5.5. Others
5.4.5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6. RCA/MDA
5.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6.2. Pharma & Biotech
5.4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6.2.2. Research
5.4.6.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6.2.3. Therapeutics/Production
5.4.6.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6.3. Academic & Research
5.4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6.4. Hospital & Diagnostics
5.4.6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.6.5. Others
5.4.6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7. RNA Therapeutics
5.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7.2. Pharma & Biotech
5.4.7.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7.2.2. Research
5.4.7.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7.2.3. Therapeutics/Production
5.4.7.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7.3. Academic & Research
5.4.7.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7.4. Hospital & Diagnostics
5.4.7.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.7.5. Others
5.4.7.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8. Transcriptomics
5.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8.2. Pharma & Biotech
5.4.8.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8.2.2. Research
5.4.8.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8.2.3. Therapeutics/Production
5.4.8.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8.3. Academic & Research
5.4.8.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8.4. Hospital & Diagnostics
5.4.8.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.8.5. Others
5.4.8.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.9. Proteomics
5.4.9.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.9.2. Pharma & Biotech
5.4.9.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.9.2.2. Research
5.4.9.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.9.2.3. Therapeutics/Production
5.4.9.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.9.3. Academic & Research
5.4.9.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.9.4. Hospital & Diagnostics
5.4.9.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.9.5. Others
5.4.9.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.10. Liquid Biopsy
5.4.10.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.10.2. Pharma & Biotech
5.4.10.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.10.2.2. Research
5.4.10.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.10.2.3. Therapeutics/Production
5.4.10.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.10.3. Academic & Research
5.4.10.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.10.4. Hospital & Diagnostics
5.4.10.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.10.5. Others
5.4.10.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.11. Other Applications
5.4.11.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.11.2. Pharma & Biotech
5.4.11.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.11.2.2. Research
5.4.11.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.11.2.3. Therapeutics/Production
5.4.11.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.11.3. Academic & Research
5.4.11.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.11.4. Hospital & Diagnostics
5.4.11.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.11.5. Others
5.4.11.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Molecular Biology Enzymes, Reagents and Kits Market: End use Estimates & Trend Analysis
6.1. End use Market Share, 2024 & 2033
6.2. Segment Dashboard
6.3. Global Molecular Biology Enzymes, Reagents And Kits Market by End use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.4.1. Pharma & Biotech
6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.4.1.2. Research
6.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.4.1.3. Therapeutics/Production
6.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Academic & Research
6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. Hospital & Diagnostics
6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Other
6.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Molecular Biology Enzymes, Reagents and Kits Market: Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America Molecular Biology Enzymes, Reagents and Kits Market Estimates And Forecast, 2021 - 2033 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.2.2.2. Key Country Dynamics
7.2.2.3. Regulatory Framework
7.2.2.4. Reimbursement Scenario
7.2.2.5. Competitive Scenario
7.2.3. Canada
7.2.3.1. Canada Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.2.3.2. Key Country Dynamics
7.2.3.3. Regulatory Framework
7.2.3.4. Reimbursement Scenario
7.2.3.5. Competitive Scenario
7.2.4. Mexico
7.2.4.1. Mexico Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.2.4.2. Key Country Dynamics
7.2.4.3. Regulatory Framework
7.2.4.4. Reimbursement Scenario
7.2.4.5. Competitive Scenario
7.3. Europe
7.3.1. Europe Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.2. UK
7.3.2.1. UK Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.2.2. Key Country Dynamics
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Scenario
7.3.2.5. Competitive Scenario
7.3.3. Germany
7.3.3.1. Germany Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.3.2. Key Country Dynamics
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Scenario
7.3.3.5. Competitive Scenario
7.3.4. Spain
7.3.4.1. Spain Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.4.2. Key Country Dynamics
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Scenario
7.3.4.5. Competitive Scenario
7.3.5. France
7.3.5.1. France Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.5.2. Key Country Dynamics
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Scenario
7.3.5.5. Competitive Scenario
7.3.6. Italy
7.3.6.1. Italy Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.6.2. Key Country Dynamics
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Scenario
7.3.6.5. Competitive Scenario
7.3.7. Denmark
7.3.7.1. Denmark Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.7.2. Key Country Dynamics
7.3.7.3. Regulatory Framework
7.3.7.4. Reimbursement Scenario
7.3.7.5. Competitive Scenario
7.3.8. Sweden
7.3.8.1. Sweden Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.8.2. Key Country Dynamics
7.3.8.3. Regulatory Framework
7.3.8.4. Reimbursement Scenario
7.3.8.5. Competitive Scenario
7.3.9. Norway
7.3.9.1. Norway Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.3.9.2. Key Country Dynamics
7.3.9.3. Regulatory Framework
7.3.9.4. Reimbursement Scenario
7.3.9.5. Competitive Scenario
7.4. Asia Pacific
7.4.1. Asia-Pacific Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.4.2.2. Key Country Dynamics
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Scenario
7.4.2.5. Competitive Scenario
7.4.3. China
7.4.3.1. China Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.4.3.2. Key Country Dynamics
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Scenario
7.4.3.5. Competitive Scenario
7.4.4. India
7.4.4.1. India Molecular Biology Enzymes, Reagents and Kits Market, 2021 - 2033 (USD Million)
7.4.4.2. Key Country Dynamics
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Scenario
7.4.4.5. Competitive Scenario
7.4.5. South Korea
7.4.5.1. South Korea Molecular Biology Enzymes, Reagents and Kits Market, 202
°ü·ÃÀÚ·á